Live feed/
Filings
/
SCHEDULE
/
0001104659-25-041602
Stake: 6.50%
Shares: 8,335,116
CUSIP: 00091E109
Class: Common Stock, $0.0001 par value per share
Composite Decision Signal · PASS (LOW BASE-RATE EDGE)
Conviction Score: 46/100 · Filer 90d Win Rate: 100% · Hist. 90d Edge: +12.1%
- Filer track record (3 filings): 100% 90d win rate, +12.1% 90d edge
- 8 NPORT-P mutual funds holding CUSIP
- Elevated short days-to-cover (9.0 DTC)
Item 4 — Purpose of Transaction
The paragraph below is hereby added prior to the last paragraph in Item 4 of the Prior Schedule 13D: Effective as of April 25, 2025, Amrit Nagpal resigned from his position as a member of the Issuer's Board of Directors. Mr. Nagpal's resignation was not the result of any disagreement with the Issuer on any matter regarding its operations, policies, or practices.
Cross-References
Insider Activity (last 365d)
5 transactions
2 buys · 0 sales · 0 awards/exercises
Issuer Cluster
2 13D/G filings on this issuer
1 other filing besides this one
Filer Track Record
24 filings by this filer
23 other filings in the data moat
Short Interest · settle 2026-10-15
DTC 8.99
37,016,055 shares short · -1.1% vs prior
Post-Filing Returns · since 2025-04-25 on ABSI
Anchor price 3.13 on closest trading day on/after 2025-04-25. Source: Yahoo Finance daily adj_close (split + dividend adjusted).
Form 4 Insider Transactions · last 365d
| Date | Insider | Role | Type | Shares | Price | Value |
|---|
| 2026-10-12 |
McClain Sean |
director, officer |
F |
23,293 |
$10.16 |
$237K |
| 2026-10-12 |
Bedrick Todd |
officer |
F |
22,325 |
$10.16 |
$227K |
| 2026-10-12 |
Jonasson Zachariah |
officer |
F |
387 |
$10.16 |
$4K |
| 2026-06-04 |
Szela Mary T |
director |
Award |
10,100 |
— |
— |
| 2026-06-04 |
Szela Mary T |
director |
Award |
39,800 |
$7.34 |
$292K |
Other 13D/G Filings on Absci Corp
| Filed | Form | Filer | Stake | Shares | |
|---|
| 2023-03-20 |
SC |
Casdin Capital, LLC |
— |
— |
view → |
Other Filings by Redmile Group, LLC
| Filed | Form | Issuer | Stake | Shares | |
|---|
| 2026-09-28 |
SCHEDULE 13G |
Electra Therapeutics, Inc. |
— |
— |
view → |
| 2026-07-24 |
SCHEDULE 13D/A |
Atara Biotherapeutics, Inc. |
9.90% |
950,994 |
view → |
| 2026-07-17 |
SCHEDULE 13D/A |
Shattuck Labs, Inc. |
9.90% |
10,019,421 |
view → |
| 2026-06-11 |
SCHEDULE 13D/A |
Shattuck Labs, Inc. STTK |
9.90% |
9,819,084 |
view → |
| 2026-05-14 |
SCHEDULE 13D/A |
Atara Biotherapeutics, Inc. ATRA |
9.90% |
950,994 |
view → |
| 2024-07-19 |
SC |
Augmedix, Inc. |
— |
— |
view → |
| 2023-12-28 |
SC |
FATE THERAPEUTICS INC FATE |
— |
— |
view → |
| 2023-06-21 |
SC |
MedAvail Holdings, Inc. |
— |
— |
view → |
| 2023-06-13 |
SC |
IGM Biosciences, Inc. |
— |
— |
view → |
| 2023-03-15 |
SC |
MedAvail Holdings, Inc. |
— |
— |
view → |
| 2022-10-05 |
SC |
IGM Biosciences, Inc. |
— |
— |
view → |
| 2022-07-06 |
SC |
MedAvail Holdings, Inc. |
— |
— |
view → |
| 2022-01-14 |
SC |
MedAvail Holdings, Inc. |
— |
— |
view → |
| 2021-11-29 |
SC |
MedAvail Holdings, Inc. |
— |
— |
view → |
| 2021-03-01 |
SC |
Augmedix, Inc. |
— |
— |
view → |
| 2021-01-12 |
SC |
FATE THERAPEUTICS INC FATE |
— |
— |
view → |
| 2020-12-15 |
SC |
IGM Biosciences, Inc. |
— |
— |
view → |
| 2020-09-10 |
SC |
IGM Biosciences, Inc. |
— |
— |
view → |
| 2019-10-24 |
SC |
ALDER BIOPHARMACEUTICALS INC |
— |
— |
view → |
| 2019-09-17 |
SC |
FATE THERAPEUTICS INC FATE |
— |
— |
view → |
Showing 20 of 23
Want this depth on every filing the moment it hits SEC EDGAR?
Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.
See pricing →